Posts by ericg
Five things: Cannabis lawsuit, Millennium’s ‘crazy idea’ and answering tough questions
Good morning, Boston. Here are the five things you need to know in Boston business news to start your Friday. Read More
Read MorePartners with a Purpose: American Tower Corp. and USES
When the Covid-19 pandemic hit, employees at American Tower Corp. realized how vital connectivity became for school and work in daily life. Workers at the Back Bay-based company sprang into action when they realized that their neighbors, the United South End Settlement, were struggling to keep up with the fast-changing world. Read More
Read MoreForm D Friday: ‘Marketplace for motherhood’ startup raises initial funding
Form D Friday is a Boston Business Journal feature highlighting regulatory filings from Boston-area companies raising capital for new projects or expanding their businesses. Read More
Read MoreLaw firm mergers hit three-year high
Nationally, law firm merger activity is outpacing 2022 and 2021 levels, with 41 completed mergers in the first nine month the year, according to a new report. Read More
Read MoreDartmouth Mall owner PREIT wins reprieve from debt trouble — for now
A loan on Dartmouth Mall was placed into special servicing earlier this year amid a tough refinancing environment. An updated appraisal puts the retail property’s value at almost half of what it was in 2013. Read More
Read MoreCannabis chair pauses lawsuit against state treasurer
Shannon O’Brien, the state’s top cannabis regulator who was suspended by State Treasurer Deb Goldberg last month, has put her lawsuit against the treasurer on hold. Read More
Read MoreBostInno Approved: Here are the October events you need to know about
Check out Boston’s tech and startup events in October, including Boston Fintech Week, the Tech Breakfast Club, the Techstars Boston fall fireside chat and more. Read More
Read MoreJapanese pharma giant scoops up Seaport biotech for $387.4M
A Japanese pharmaceutical giant is buying a Boston-London biotech for $387.4 million. Read More
Read MoreGene therapy firm to close Lexington research lab amid 114-person layoff
A year after it scored a major win in the form of an FDA approval, a gene therapy firm is retooling things, closing a Lexington research lab amid a 114-person layoff. Read More
Read MoreFour Boston-area biotechs await high-profile drug approval decisions this year
Some of the largest Boston-area biotech and pharmaceutical companies are still hoping to net drug approvals from the FDA by the end of 2023. Read More
Read More